Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Vogelezang CJ"'
Autor:
van Veen HA; Pharming Technologies B.V., Leiden, The Netherlands. h.veen@pharming.com, Koiter J, Vogelezang CJ, van Wessel N, van Dam T, Velterop I, van Houdt K, Kupers L, Horbach D, Salaheddine M, Nuijens JH, Mannesse ML
Publikováno v:
Journal of biotechnology [J Biotechnol] 2012 Dec 31; Vol. 162 (2-3), pp. 319-26. Date of Electronic Publication: 2012 Sep 17.
Autor:
Ziere GJ; Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, University of Leiden, The Netherlands., van der Kaaden ME, Vogelezang CJ, Boers W, Bihain BE, Kuiper J, Kruijt JK, van Berkel TJ
Publikováno v:
European journal of biochemistry [Eur J Biochem] 1996 Dec 15; Vol. 242 (3), pp. 703-11.
Autor:
De Rijke YB; Division of Biopharmaceutics Leiden-Amsterdam Center for Drug Research, University of Leiden, Netherlands., Verwey HF, Vogelezang CJ, Van Der Velde EA, Princen HM, Van Der Laarse A, Bruschke AV, Van Berkel TJ
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 1995 Dec 29; Vol. 243 (2), pp. 137-49.
Autor:
van Berkel TJ; Division of Biopharmaceutics, University of Leiden, Netherlands., Fluiter K, van Velzen AG, Vogelezang CJ, Ziere GJ
Publikováno v:
Atherosclerosis [Atherosclerosis] 1995 Dec; Vol. 118 Suppl, pp. S43-50.
Autor:
De Rijke YB; Division of Biopharmaceutics, Leiden-Amsterdam Center for Drug Research (LACDR), Sylvius Laboratories, University of Leiden, The Netherlands., Biessen EA, Vogelezang CJ, van Berkel TJ
Publikováno v:
The Biochemical journal [Biochem J] 1994 Nov 15; Vol. 304 ( Pt 1), pp. 69-73.
Autor:
de Rijke YB, Vogelezang CJ, van Berkel TJ, Princen HM, Verwey HF, van der Laarse A, Bruschke AV
Publikováno v:
Lancet (London, England) [Lancet] 1992 Oct 03; Vol. 340 (8823), pp. 858-9.